Khan et al. revealed that the HECT-domain in the E3 ubiquitin ligase TRIP12 is indispensable for proteasomal degradation of the tumour suppressor FBW7 to sensitise cells to Taxol chemotherapy [37]. This evidence concerns the gene FBXW7 and neoplasm.